Assurant, Inc. (AIZ) Stock Analysis
Is AIZ a good investment?
Assurant, Inc. (AIZ) has a Plutrex AI rating of 68.0/100 as of November 12, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Exceptional Q3 2026 results: 9-month GAAP net income +31% YoY to $847.9M and Adjusted EBITDA +26% to $1.385B — operational execution is demonstrably strong and management raised full-year 2026 guidance, validating the long-duration 5-year EPS CAGR thesis of 9.49% (227% above P&C industry average of 2.90%). Main concern: Valuation has become stretched after the 13.5% price surge: analyst consensus target of $332.00 implies only 2.7% upside from $323.38 — the risk/reward at current price is approximately 0.30:1 to analyst target vs. a $295 stop, catastrophically below the minimum 3.0:1 threshold for new entries; P/E expanded from 13.52x to 15.09x with the consensus target virtually unmoved ($331→$332).
Investment Summary
AIZ (Assurant) at $323.38 is a high-quality specialty insurer that has surged 13.5% since my prior report 14 days ago — entirely on the back of strong Q3 2026 results (9-month GAAP net income +31% YoY to $847.9M, Adjusted EBITDA +26% to $1.385B) and a raised full-year outlook. The fundamental quality remains intact: ROE of 18.3% (vs. cost of equity ~9%), FCF of $1.83B, D/E of only 0.32x, and 5-year forward EPS CAGR of 9.49% that is 227% above the P&C industry average of 2.90%. However, the price surge has materially worsened the entry math. P/E has expanded from 13.52x to 15.09x (+11.6%) with zero change to the analyst consensus target ($331→$332, +0.3%). The stock now sits only 2.7% below the consensus target of $332, implying virtually no upside margin of safety. At $323.38, the risk/reward to analyst target vs. a reasonable stop of $295 is ($332−$323.38)/($323.38−$295) = $8.62/$28.38 = 0.30:1 — deeply unattractive. The exceptional Q3 results are real and the raised outlook is a genuine positive, but these are now reflected in the price. For existing holders, this is a solid hold with a tightening stop. For new buyers, the price has run well past any reasonable entry zone and the risk/reward does not meet minimum standards.
Key Strengths
- Exceptional Q3 2026 results: 9-month GAAP net income +31% YoY to $847.9M and Adjusted EBITDA +26% to $1.385B — operational execution is demonstrably strong and management raised full-year 2026 guidance, validating the long-duration 5-year EPS CAGR thesis of 9.49% (227% above P&C industry average of 2.90%)
- Capital efficiency fortress: ROE of 18.3% on D/E of only 0.32x, FCF of $1.83B annually, and $2.08B cash — the business is fully self-funding with no need for external capital, supporting continued buybacks (YoY EPS growth of 27.9% vs. earnings growth of 6.2% confirms aggressive share count reduction) and dividends
- PEG ratio of 1.59 is 49% BELOW the P&C industry average of 3.12 — despite a P/E premium of 33.9% vs. peers, AIZ's superior growth (9.49% 5-year CAGR vs. 2.90% industry) makes it the more attractively priced security on a growth-adjusted basis, confirming the long-duration compounder thesis
Key Concerns
- Valuation has become stretched after the 13.5% price surge: analyst consensus target of $332.00 implies only 2.7% upside from $323.38 — the risk/reward at current price is approximately 0.30:1 to analyst target vs. a $295 stop, catastrophically below the minimum 3.0:1 threshold for new entries; P/E expanded from 13.52x to 15.09x with the consensus target virtually unmoved ($331→$332)
- Structural margin inferiority persists and is UNCHANGED: operating margin of 10.8% is 40.9% below the industry average of 18.28%; net margin of 7.8% is 42.2% below the industry average of 13.49% — AIZ's specialty mix (mobile device protection, warranty, lifestyle insurance) inherently carries higher operating cost structures than traditional P&C underwriters, limiting multiple expansion even with superior growth delivery
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
AIZ's fundamentals score well on quality but poorly on valuation at current prices. ROE of 18.3% significantly exceeds cost of equity (~9%), confirming genuine economic value creation. FCF of $1.83B is prolific — representing a 5.65% FCF yield at the prior price of $285 but only 5.11% FCF yield at $323 (still reasonable but declining). D/E of 0.32x is conservative, leaving ample borrowing capacity. Net margin of 7.8% and operating margin of 10.8% are structurally below the P&C industry averages of 13.5% and 18.3% respectively — a persistent business-model-linked weakness. P/E of 15.09x vs. industry average of 11.27x represents a 33.9% premium. PEG of 1.59 (using 5-year EPS CAGR of 9.49%) is BELOW the industry average PEG of 3.12 — the growth-adjusted valuation remains more attractive than peers. However, next-year EPS growth of -0.3% means the near-term P/E is effectively infinite on an earnings-growth basis. Revenue growth of 9.2% (vs. industry 1.04%) is a dominant competitive advantage. The intrinsic value DCF range of $310-$340 means the stock at $323 is in the middle of fair value — not cheap, not expensive in isolation, but with only 2.7% upside to the $332 consensus target, the asymmetry is unfavorable.
News Sentiment
Assurant delivered a blockbuster quarter that sent shares surging, but investors now face a classic 'good news priced in' dilemma. The specialty insurance giant reported nine-month 2026 GAAP net income soaring 31% year-over-year to $847.9 million, with Adjusted EBITDA climbing 26% to $1.385 billion — numbers that signal the company's connected device and lifestyle protection segments are firing on all cylinders. Management followed up with a rare confidence booster: raising the full-year 2026 outlook for both Adjusted EBITDA and Adjusted EPS growth, a move that typically signals executives see clear visibility into fourth-quarter results. The Q3 earnings call transcript, widely covered and analyzed, revealed an execution story that's hard to argue with — disciplined underwriting, bolt-on acquisitions building out niche verticals, and a buyback program aggressively compressing share count. Analysts noting upward earnings estimate revisions suggest Wall Street is warming to the story further. One headline asked 'Why Assurant Might be Well Poised for a Surge' — and in the two weeks since, that surge already happened, with shares rallying 13.5% to $323. The company even made the 'Best Value Stocks' list, though at current prices that value argument is harder to make with only 2.7% upside to the analyst consensus target of $332. The business story has never been better — but for new investors, the price may have gotten there first.
Risk Assessment
PRIMARY RISK: Price has run 13.5% beyond the prior entry zone in 14 days — the stock is now trading at the upper bound of intrinsic value ($310-$340 DCF range) with only 2.7% upside to analyst consensus. Any disappointment in Q4 guidance, claims normalization, or macro deterioration (rising catastrophe losses) could trigger a correction back toward the $295-$308 zone. VALUATION RISK: P/E of 15.09x with next-year EPS growth of -0.3% creates a 'growth air pocket' risk — if Q4 or early 2027 earnings disappoint, the multiple could compress. At 13x trailing P/E (a reasonable bear-case multiple), AIZ would trade near $279. STRUCTURAL RISK: Margin inferiority vs. peers (operating margin 10.8% vs. 18.3% industry) is structural, not cyclical — multiple expansion is capped unless AIZ demonstrates margin improvement. MITIGATION: Exceptional FCF ($1.83B), low D/E (0.32x), and $2.08B cash provide a substantial balance sheet buffer. The raised full-year guidance and strong Q3 reduce near-term earnings risk. Wait for pullback to $295-$308 for new entries.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is AIZ a halal stock?
No, Assurant, Inc. (AIZ) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for AIZ?
Assurant, Inc. (AIZ) has a Plutrex AI rating of 68.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is AIZ a good investment?
According to Plutrex AI, AIZ has a Buy rating (68.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in AIZ?
US stocks like AIZ can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in AIZ?
Plutrex AI identifies the main risks for AIZ by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.